Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 12Solid Tumors 1Shock, Septic 1Neoplasms 1Metabolic Syndrome 1Menstruation Disturbances 1Insulin Resistance 1Infertility, Female 1Hodgkin Disease 1Cardiovascular Diseases 1

Interventions

Metformin 30Exercise 8Pioglitazone 7Inositol 6Insulin 5Acupuncture Therapy 4High-Intensity Interval Training 3Ethinyl Estradiol 3salicylsalicylic acid 2drospirenone and ethinyl estradiol combination 2Water 2Tablets 2Surveys and Questionnaires 2Sugars 2Resistance Training 2Preoperative Exercise 2Observation 2Folic Acid 2Diet Therapy 2Cyproterone Acetate 2Cholecalciferol 2Caloric Restriction 2Biguanides 2ziprasidone 1maltodextrin 1lime 1licogliflozin 1exendin (9-39) 1drospirenone 1cinnulin PF 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Insulin Resistance × Contraceptives, Oral × Clear all
NCT00948402 2009-10-14

PED/PEA-15 Protein, PCOS, Obesity, Insulin Sensitivity Indexes, Metformin, Oral Contraceptives

Federico II University

Phase 3 Completed
20 enrolled

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡